vs

Side-by-side financial comparison of DILLARD'S, INC. (DDS) and Roper Technologies (ROP). Click either name above to swap in a different company.

Roper Technologies is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× DILLARD'S, INC.). Roper Technologies runs the higher net margin — 15.8% vs 8.8%, a 7.0% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs 2.9%). Roper Technologies produced more free cash flow last quarter ($507.0M vs $156.2M). Over the past eight quarters, Roper Technologies's revenue compounded faster (10.5% CAGR vs -16.9%).

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

DDS vs ROP — Head-to-Head

Bigger by revenue
ROP
ROP
1.4× larger
ROP
$2.1B
$1.5B
DDS
Growing faster (revenue YoY)
ROP
ROP
+8.4% gap
ROP
11.3%
2.9%
DDS
Higher net margin
ROP
ROP
7.0% more per $
ROP
15.8%
8.8%
DDS
More free cash flow
ROP
ROP
$350.8M more FCF
ROP
$507.0M
$156.2M
DDS
Faster 2-yr revenue CAGR
ROP
ROP
Annualised
ROP
10.5%
-16.9%
DDS

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
DDS
DDS
ROP
ROP
Revenue
$1.5B
$2.1B
Net Profit
$129.8M
$331.0M
Gross Margin
43.4%
69.4%
Operating Margin
11.5%
27.2%
Net Margin
8.8%
15.8%
Revenue YoY
2.9%
11.3%
Net Profit YoY
4.2%
842.6%
EPS (diluted)
$8.31
$4.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDS
DDS
ROP
ROP
Q1 26
$2.1B
Q4 25
$1.5B
$2.1B
Q3 25
$1.5B
$2.0B
Q2 25
$1.5B
$1.9B
Q1 25
$2.0B
$1.9B
Q4 24
$1.4B
$1.9B
Q3 24
$1.5B
$1.8B
Q2 24
$1.5B
$1.7B
Net Profit
DDS
DDS
ROP
ROP
Q1 26
$331.0M
Q4 25
$129.8M
$428.4M
Q3 25
$72.8M
$398.5M
Q2 25
$163.8M
$378.3M
Q1 25
$214.4M
$331.1M
Q4 24
$124.6M
$462.3M
Q3 24
$74.5M
$367.9M
Q2 24
$180.0M
$337.1M
Gross Margin
DDS
DDS
ROP
ROP
Q1 26
69.4%
Q4 25
43.4%
69.5%
Q3 25
36.6%
69.5%
Q2 25
43.9%
69.2%
Q1 25
34.9%
68.7%
Q4 24
42.6%
68.3%
Q3 24
37.6%
69.2%
Q2 24
44.6%
69.5%
Operating Margin
DDS
DDS
ROP
ROP
Q1 26
27.2%
Q4 25
11.5%
28.6%
Q3 25
6.2%
28.4%
Q2 25
14.0%
28.2%
Q1 25
11.7%
27.9%
Q4 24
11.4%
28.0%
Q3 24
6.5%
28.1%
Q2 24
15.2%
28.8%
Net Margin
DDS
DDS
ROP
ROP
Q1 26
15.8%
Q4 25
8.8%
20.8%
Q3 25
4.8%
19.8%
Q2 25
10.7%
19.5%
Q1 25
10.6%
17.6%
Q4 24
8.7%
24.6%
Q3 24
5.0%
20.8%
Q2 24
11.6%
19.6%
EPS (diluted)
DDS
DDS
ROP
ROP
Q1 26
$4.87
Q4 25
$8.31
$3.97
Q3 25
$4.66
$3.68
Q2 25
$10.39
$3.49
Q1 25
$13.41
$3.06
Q4 24
$7.73
$4.29
Q3 24
$4.59
$3.40
Q2 24
$11.09
$3.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDS
DDS
ROP
ROP
Cash + ST InvestmentsLiquidity on hand
$1.1B
$382.9M
Total DebtLower is stronger
$9.7B
Stockholders' EquityBook value
$2.0B
$18.8B
Total Assets
$4.3B
$34.6B
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDS
DDS
ROP
ROP
Q1 26
$382.9M
Q4 25
$1.1B
$297.4M
Q3 25
$1.0B
$320.0M
Q2 25
$900.5M
$242.4M
Q1 25
$717.9M
$372.8M
Q4 24
$980.4M
$188.2M
Q3 24
$946.7M
$269.6M
Q2 24
$817.8M
$251.5M
Total Debt
DDS
DDS
ROP
ROP
Q1 26
$9.7B
Q4 25
$9.3B
Q3 25
Q2 25
Q1 25
Q4 24
$7.6B
Q3 24
Q2 24
Stockholders' Equity
DDS
DDS
ROP
ROP
Q1 26
$18.8B
Q4 25
$2.0B
$19.9B
Q3 25
$1.9B
$20.0B
Q2 25
$1.9B
$19.6B
Q1 25
$1.8B
$19.2B
Q4 24
$2.0B
$18.9B
Q3 24
$1.9B
$18.5B
Q2 24
$1.9B
$18.1B
Total Assets
DDS
DDS
ROP
ROP
Q1 26
$34.6B
Q4 25
$4.3B
$34.6B
Q3 25
$3.7B
$34.6B
Q2 25
$3.9B
$33.2B
Q1 25
$3.5B
$31.4B
Q4 24
$4.1B
$31.3B
Q3 24
$3.7B
$31.6B
Q2 24
$3.9B
$29.8B
Debt / Equity
DDS
DDS
ROP
ROP
Q1 26
0.52×
Q4 25
0.47×
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDS
DDS
ROP
ROP
Operating Cash FlowLast quarter
$186.5M
Free Cash FlowOCF − Capex
$156.2M
$507.0M
FCF MarginFCF / Revenue
10.6%
24.2%
Capex IntensityCapex / Revenue
2.1%
0.5%
Cash ConversionOCF / Net Profit
1.44×
TTM Free Cash FlowTrailing 4 quarters
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDS
DDS
ROP
ROP
Q1 26
Q4 25
$186.5M
$738.0M
Q3 25
$86.8M
$869.5M
Q2 25
$232.6M
$404.1M
Q1 25
$364.7M
$528.7M
Q4 24
$173.5M
$722.2M
Q3 24
$-68.4M
$755.4M
Q2 24
$244.4M
$384.1M
Free Cash Flow
DDS
DDS
ROP
ROP
Q1 26
$507.0M
Q4 25
$156.2M
Q3 25
$60.1M
Q2 25
$215.8M
Q1 25
$349.3M
Q4 24
$145.4M
Q3 24
$-94.3M
Q2 24
$209.2M
FCF Margin
DDS
DDS
ROP
ROP
Q1 26
24.2%
Q4 25
10.6%
Q3 25
4.0%
Q2 25
14.1%
Q1 25
17.3%
Q4 24
10.2%
Q3 24
-6.3%
Q2 24
13.5%
Capex Intensity
DDS
DDS
ROP
ROP
Q1 26
0.5%
Q4 25
2.1%
Q3 25
1.8%
Q2 25
1.1%
Q1 25
0.8%
Q4 24
2.0%
Q3 24
1.7%
Q2 24
2.3%
Cash Conversion
DDS
DDS
ROP
ROP
Q1 26
Q4 25
1.44×
1.72×
Q3 25
1.19×
2.18×
Q2 25
1.42×
1.07×
Q1 25
1.70×
1.60×
Q4 24
1.39×
1.56×
Q3 24
-0.92×
2.05×
Q2 24
1.36×
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons